# Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy

> **NCT02553785** · PHASE1 · COMPLETED · sponsor: **BioVentrix** · enrollment: 89 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Revivent TC

## Key facts

- **NCT ID:** NCT02553785
- **Lead sponsor:** BioVentrix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 89 (ESTIMATED)
- **Last updated:** 2021-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02553785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02553785, "Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02553785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*